Skip to Main Content

Paper Details

Oncologic Outcomes of Multi-Institutional Minimally Invasive Inguinal Lymph Node Dissection for Melanoma Compared with Open Inguinal Dissection in the Second Multicenter Selective Lymphadenectomy Trial (MSLT-II).
Ann Surg Oncol
5
2022
Melanoma, SLN, melanoma, patients
Author NameAffiliation
David Elashoffuniversity of california los angeles Medical Center
David Elashoffuniversity of california los angeles Medical Center
  • 1 - 2

Datasets

Release 1.2